VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 3 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,283,142 | -59.2% | 243,665 | +6.9% | 0.00% | -50.0% |
Q2 2023 | $5,592,422 | +8.2% | 227,983 | +2.6% | 0.00% | 0.0% |
Q1 2023 | $5,170,641 | -8.1% | 222,202 | -0.1% | 0.00% | 0.0% |
Q4 2022 | $5,627,400 | +33.6% | 222,339 | +1.8% | 0.00% | 0.0% |
Q3 2022 | $4,212,000 | -22.8% | 218,438 | +2.0% | 0.00% | 0.0% |
Q2 2022 | $5,457,000 | +283.8% | 214,257 | +287.6% | 0.00% | – |
Q1 2022 | $1,422,000 | -38.2% | 55,275 | +0.6% | 0.00% | -100.0% |
Q4 2021 | $2,301,000 | -2.0% | 54,960 | +1.9% | 0.00% | 0.0% |
Q3 2021 | $2,347,000 | +11.1% | 53,934 | +20.7% | 0.00% | 0.0% |
Q2 2021 | $2,113,000 | +45.7% | 44,680 | +57.8% | 0.00% | 0.0% |
Q1 2021 | $1,450,000 | +49.9% | 28,309 | -21.7% | 0.00% | – |
Q4 2020 | $967,000 | +3.2% | 36,160 | +32.5% | 0.00% | – |
Q3 2020 | $937,000 | -19.5% | 27,285 | -4.1% | 0.00% | -100.0% |
Q2 2020 | $1,164,000 | +2884.6% | 28,445 | +2419.5% | 0.00% | – |
Q1 2020 | $39,000 | +105.3% | 1,129 | -23.8% | 0.00% | – |
Q4 2019 | $19,000 | – | 1,482 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $38,245,753 | 30.44% |
SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $409,259,526 | 3.12% |
Octagon Capital Advisors LP | 650,100 | $15,946,953 | 2.22% |
Paradigm Biocapital Advisors LP | 1,014,239 | $24,879,283 | 1.92% |
Perceptive Advisors | 1,958,264 | $48,036,216 | 1.39% |
Avidity Partners Management LP | 1,425,000 | $34,955,250 | 1.22% |
Ghost Tree Capital, LLC | 150,000 | $3,679,500 | 1.22% |
MIRABELLA FINANCIAL SERVICES LLP | 412,008 | $10,106,556 | 1.11% |
SECTOR GAMMA AS | 150,406 | $3,689,459 | 0.83% |
Sofinnova Investments, Inc. | 488,117 | $11,973,510 | 0.78% |